These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 12497671

  • 1. Evolution of progestins. Focus on the novel progestin drospirenone.
    Thorneycroft IH.
    J Reprod Med; 2002 Nov; 47(11 Suppl):975-80. PubMed ID: 12497671
    [Abstract] [Full Text] [Related]

  • 2. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
    Dickerson V.
    J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP.
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [Abstract] [Full Text] [Related]

  • 4. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of different progestogens: the special case of drospirenone.
    Sitruk-Ware R.
    Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650
    [Abstract] [Full Text] [Related]

  • 6. YAZ and the novel progestin drospirenone.
    Mishell DR.
    J Reprod Med; 2008 Sep; 53(9 Suppl):721-8. PubMed ID: 18980044
    [Abstract] [Full Text] [Related]

  • 7. Drospirenone: a novel progestin.
    Rapkin AJ, Winer SA.
    Expert Opin Pharmacother; 2007 May; 8(7):989-99. PubMed ID: 17472544
    [Abstract] [Full Text] [Related]

  • 8. A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
    Oner G, Muderris II.
    Contraception; 2011 Nov; 84(5):508-11. PubMed ID: 22018126
    [Abstract] [Full Text] [Related]

  • 9. Oral contraception: trends over time.
    Yuzpe AA.
    J Reprod Med; 2002 Nov; 47(11 Suppl):967-73. PubMed ID: 12497670
    [Abstract] [Full Text] [Related]

  • 10. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
    Muhn P, Fuhrmann U, Fritzemeier KH, Krattenmacher R, Schillinger E.
    Ann N Y Acad Sci; 1995 Jun 12; 761():311-35. PubMed ID: 7625729
    [Abstract] [Full Text] [Related]

  • 11. Added benefits of drospirenone for compliance.
    Foidart JM.
    Climacteric; 2005 Oct 12; 8 Suppl 3():28-34. PubMed ID: 16203653
    [Abstract] [Full Text] [Related]

  • 12. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
    Muhn P, Krattenmacher R, Beier S, Elger W, Schillinger E.
    Contraception; 1995 Feb 12; 51(2):99-110. PubMed ID: 7750297
    [Abstract] [Full Text] [Related]

  • 13. Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.
    Oelkers W.
    Eur J Contracept Reprod Health Care; 2000 Dec 12; 5 Suppl 3():17-24. PubMed ID: 11246598
    [Abstract] [Full Text] [Related]

  • 14. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
    Somma MA.
    Am Fam Physician; 2004 May 15; 69(10):2425-6. PubMed ID: 15168965
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
    De Leo V, Morgante G, Piomboni P, Musacchio MC, Petraglia F, Cianci A.
    Fertil Steril; 2007 Jul 15; 88(1):113-7. PubMed ID: 17418832
    [Abstract] [Full Text] [Related]

  • 16. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.
    Oelkers W.
    Eur J Contracept Reprod Health Care; 2002 Dec 15; 7 Suppl 3():19-26; discussion 42-3. PubMed ID: 12659403
    [Abstract] [Full Text] [Related]

  • 17. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
    Rübig A.
    Climacteric; 2003 Oct 15; 6 Suppl 3():49-54. PubMed ID: 15018248
    [Abstract] [Full Text] [Related]

  • 18. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen.
    Krattenmacher R.
    Contraception; 2000 Jul 15; 62(1):29-38. PubMed ID: 11024226
    [Abstract] [Full Text] [Related]

  • 19. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH.
    Climacteric; 2005 Oct 15; 8 Suppl 3():19-27. PubMed ID: 16203652
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb 15; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.